Details of the Drug Reposition

General Information of This Drug (ID: DMHFBOG)

Drug Name	SAR231893 DMHFBOG

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Asthma	DISW9QNS	CA23	Phase 3	[1]
Atopic dermatitis	DISTCP41	EA80	Phase 3	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02134028) Long-Term Safety Evaluation of Dupilumab in Patients With Asthma. U.S. National Institutes of Health.